Ciglitazone ameliorates lung inflammation by modulating the inhibitor κB protein kinase/nuclear factor-κB pathway after hemorrhagic shock

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume 36, Issue 10, Pages 2849-2857

出版商

Ovid Technologies (Wolters Kluwer Health)

发表日期

2008-09-23

DOI

10.1097/ccm.0b013e318187810e

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started